Kuniss, M., Pavlović, N., Velagić, V., Hermida, J. S., Healey, S., Arena, G. ... Chierchia, G. B. (2021). Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. EP Europace, 23. (7), 1033-1041. doi: 10.1093/europace/euab029
Kuniss, Malte, et al. "Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation." EP Europace, vol. 23, no. 7, 2021, pp. 1033-1041. https://doi.org/10.1093/europace/euab029
Kuniss, Malte, Nikola Pavlović, Vedran Velagić, Jean Sylvain Hermida, Stewart Healey, Giuseppe Arena, Nicolas Badenco, et al. "Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation." EP Europace 23, no. 7 (2021): 1033-1041. https://doi.org/10.1093/europace/euab029
Kuniss, M., et al. (2021) 'Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation', EP Europace, 23(7), pp. 1033-1041. doi: 10.1093/europace/euab029
Kuniss M, Pavlović N, Velagić V, Hermida JS, Healey S, Arena G, and sur.. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. EP Europace [Internet]. 2021 July 18 [cited 2024 August 26];23(7):1033-1041. doi: 10.1093/europace/euab029
M. Kuniss, et al., "Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation", EP Europace, vol. 23, no. 7, pp. 1033-1041, July 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:223841. [Accessed: 26 August 2024]